Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jul;126(7):525-529.
doi: 10.1177/0003489417702655. Epub 2017 May 5.

Aggressive Salivary Malignancies at Early Stage: Outcomes and Implications for Treatment

Affiliations

Aggressive Salivary Malignancies at Early Stage: Outcomes and Implications for Treatment

Robert W Eppsteiner et al. Ann Otol Rhinol Laryngol. 2017 Jul.

Abstract

Background: Few studies have examined whether the use of adjuvant treatment impacts survival for early stage high-grade salivary tumors.

Methods: A retrospective review of the SEER database between 1973 and 2012 was performed. Patients with high-grade major salivary gland tumors including salivary duct carcinoma, carcinoma ex-pleomorphic adenoma, high-grade mucoepidermoid carcinoma, or adenocarcinoma, NOS were identified. Only stage I-II tumors were included. The impact of radiation status on observed and relative survival was examined.

Results: Five hundred seventy-four patients with high-grade, early stage salivary tumors met inclusion criteria. Sixty-seven percent of patients received radiation therapy. There was no difference in observed or relative survival based on having received radiation.

Conclusions: Adjuvant radiation is indicated for advanced stage tumors or early stage tumors with adverse features. For early stage tumors without adverse features, there was no survival benefit from radiation therapy. Adjuvant radiation should be decided on a case-by-case basis for these patients.

Keywords: cancer; malignancy; radiation; salivary gland cancer; treatment of head and neck tumors.

PubMed Disclaimer

Similar articles

Cited by

MeSH terms

LinkOut - more resources